For nearly a decade, ReturnLogic has been focused on helping ecommerce brands simplify returns through flexible workflows, automation, and actionable data. Along the way, we’ve had the opportunity to work with incredible merchants who trusted us to become a core part of their business, and we’re incredibly proud of what we’ve built together. Today, we’re excited to share the next chapter. ReturnLogic has been acquired by Redo…
News
Hydrosat Awarded NASA Contract
NASA has awarded Hydrosat a contract for commercial satellite data through its Commercial Satellite Data Acquisition (CSDA) Program. The multi-award IDIQ has a maximum value of $476 million and adds Hydrosat to NASA’s commercial data provider network for future Earth observation data acquisition. Soon, researchers and approved users will be able to access Hydrosat’s thermal and multispectral data products through the NASA Satellite Data Explorer…
Bluprynt and Chainproof Launch Verified D&O Insurance for Digital Assets
Bluprynt and Chainproof have launched Verified D&O insurance, a specialized coverage solution for the digital asset economy. This partnership provides crypto-native companies with institutional-grade protection, leveraging Bluprynt’s compliance data and Chainproof’s underwriting expertise to secure digital asset liability coverage for executives…
Matic Secures Investment and Makes Acquisition
Matic, a leading embedded insurance platform, today announced a strategic growth investment from Primus Capital alongside the acquisition of Policygenius’ property and casualty insurance portfolio, marking continued momentum in the company’s expansion…
PlanGap Releases Social Security Survey Results
PlanGap, the product innovation company pioneering a new class of policy risk insurance solutions, today released the findings of its sixth annual Social Security Confidence Survey. The nationally representative study of 1,082 U.S. adults ages 45 and older found that confidence in the future of Social Security remains low, while concerns about artificial intelligence and job security are beginning to enter the retirement anxiety conversation…
Labcorp Launches ColoSense Nationwide
Labcorp announced the nationwide availability of ColoSense, an RNA-based at-home screening test for colorectal cancer approved by the Food and Drug Administration (FDA). Offered through a commercial collaboration with test developer Geneoscopy, the test expands Labcorp’s range of colorectal cancer screening solutions. The test is now covered for eligible Medicare and Medicare Advantage beneficiaries following an update to the National Coverage Determination by the Centers for Medicare & Medicaid Services in June, with additional commercial coverage also available…
Capacity Reaches $100M in ARR
Capacity, the agentic support automation platform, today announced it has surpassed $100 million in annual recurring revenue (ARR). The company now serves more than 20,000 organizations, including 20% of the Fortune 50, having grown ARR from $5 million to $100 million in just 3.5 years, making it one of the few independent AI customer experience companies to reach the milestone…
New York Magazine Reviews Summersalt
As a certified beach bum, my swimsuits make up the bulk of my summer wardrobe. While I somehow only own a single pair of denim shorts, I could wear a different swimsuit every day for weeks before I would have to repeat. But out of all of my many options, a single one-piece stands above all the rest: Summersalt’s Sidestroke…
BitSight Releases 2026 ICS/OT Exposure Report
ICS/OT exposure is as much a local problem as a supply chain risk. As Bitsight’s Uncovering Cyber Risks in the Global Supply Chain report showed, the global digital supply chain is a tangled web of shared dependencies. Some vendors support tens of thousands of customers; others, while serving only a handful, account for up to 30% of revenue-weighted market share in a sector…
American Cancer Society Recommends ColoSense
The guideline includes additional stool-based tests: an upgraded version of Cologuard, called Cologuard Plus, and a new FDA-approved test called ColoSense, which was developed by the biotech company Geneoscopy. Each is an at-home stool test, in which samples are collected at home and sent to a lab, where the test can detect molecular markers associated with colorectal cancer…
